Ex Vivo Costimulatory Blockade to Generate Regulatory T Cells From Patients Awaiting Kidney Transplantation

39Citations
Citations of this article
37Readers
Mendeley users who have this article in their library.

Abstract

Short-term outcomes of kidney transplantation have improved dramatically, but chronic rejection and regimen-related toxicity continue to compromise overall patient outcomes. Development of regulatory T cells (Tregs) as a means to decrease alloresponsiveness and limit the need for pharmacologic immunosuppression is an active area of preclinical and clinical investigation. Nevertheless, the immunomodulatory effects of end-stage renal disease on the efficacy of various strategies to generate and expand recipient Tregs for kidney transplantation are incompletely characterized. In this study, we show that Tregs can be successfully generated from either freshly isolated or previously cryopreserved uremic recipient (responder) and healthy donor (stimulator) peripheral blood mononuclear cells using the strategy of ex vivo costimulatory blockade with belatacept during mixed lymphocyte culture. Moreover, these Tregs maintain a CD3+CD4+CD25+CD127lo surface phenotype, high levels of intracellular FOXP3 and significant demethylation of the FOXP3 Treg-specific demethylation region on allorestimulation with donor stimulator cells. These data support evaluation of this simple, brief Treg production strategy in clinical trials of mismatched kidney transplantation.

References Powered by Scopus

Rapamycin selectively expands CD4<sup>+</sup>CD25<sup>+</sup>FoxP3 <sup>+</sup> regulatory T cells

1020Citations
N/AReaders
Get full text

Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: Safety profile and detection kinetics

890Citations
N/AReaders
Get full text

Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation

884Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Past, present, and future of regulatory T cell therapy in transplantation and autoimmunity

405Citations
N/AReaders
Get full text

Regulatory cell therapy in kidney transplantation (The ONE Study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1/2A trials

296Citations
N/AReaders
Get full text

Polyclonal Regulatory T Cell Therapy for Control of Inflammation in Kidney Transplants

181Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Guinan, E. C., Cole, G. A., Wylie, W. H., Kelner, R. H., Janec, K. J., Yuan, H., … Markmann, J. (2016). Ex Vivo Costimulatory Blockade to Generate Regulatory T Cells From Patients Awaiting Kidney Transplantation. American Journal of Transplantation, 16(7), 2187–2195. https://doi.org/10.1111/ajt.13725

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 15

68%

Researcher 6

27%

Lecturer / Post doc 1

5%

Readers' Discipline

Tooltip

Medicine and Dentistry 10

43%

Immunology and Microbiology 9

39%

Agricultural and Biological Sciences 3

13%

Design 1

4%

Save time finding and organizing research with Mendeley

Sign up for free